The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial Meeting Abstract

International Collaboration

cited authors

  • Eisenberg, Mark J.; Windle, Sarah B.; Roy, Nathalie; Old, Wayne; Grondin, Franois; Bata, Iqbal; Iskander, Ayman; lauzon, Claude; Srivastava, Nalin; Clarke, Adam; Cassavar, Daniel; Dion, Danielle; Haught, Herbert; Mehta, Shamir; Baril, Jean-Francois; Lambert, Charles; Madan, Mina; Abramson, Beth L.; Dehghani, Payam

Publication Date

  • December 8, 2015

webpage

published in

category

keywords

  • Acute coronary syndromes
  • Clinical trials
  • Smoking

start page

  • 2269

end page

  • 2270

volume

  • 132

issue

  • 23